Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES LUPIN INDOCO REMEDIES/
LUPIN
 
P/E (TTM) x 30.0 40.7 73.7% View Chart
P/BV x 2.9 6.0 49.2% View Chart
Dividend Yield % 0.7 0.2 277.0%  

Financials

 INDOCO REMEDIES   LUPIN
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-23
LUPIN
Mar-23
INDOCO REMEDIES/
LUPIN
5-Yr Chart
Click to enlarge
High Rs423799 53.0%   
Low Rs308583 52.8%   
Sales per share (Unadj.) Rs181.1365.8 49.5%  
Earnings per share (Unadj.) Rs15.49.8 156.9%  
Cash flow per share (Unadj.) Rs23.129.2 79.1%  
Dividends per share (Unadj.) Rs2.254.00 56.3%  
Avg Dividend yield %0.60.6 106.3%  
Book value per share (Unadj.) Rs111.5270.7 41.2%  
Shares outstanding (eoy) m92.15454.98 20.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.01.9 106.9%   
Avg P/E ratio x23.770.2 33.7%  
P/CF ratio (eoy) x15.823.7 66.9%  
Price / Book Value ratio x3.32.6 128.4%  
Dividend payout %14.640.7 35.9%   
Avg Mkt Cap Rs m33,683314,381 10.7%   
No. of employees `000NANA-   
Total wages/salary Rs m3,22630,872 10.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m16,686166,417 10.0%  
Other income Rs m241,509 1.6%   
Total revenues Rs m16,710167,926 10.0%   
Gross profit Rs m2,86017,206 16.6%  
Depreciation Rs m7068,807 8.0%   
Interest Rs m2502,743 9.1%   
Profit before tax Rs m1,9287,165 26.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5052,688 18.8%   
Profit after tax Rs m1,4234,477 31.8%  
Gross profit margin %17.110.3 165.8%  
Effective tax rate %26.237.5 69.9%   
Net profit margin %8.52.7 316.9%  
BALANCE SHEET DATA
Current assets Rs m8,082124,513 6.5%   
Current liabilities Rs m4,24592,654 4.6%   
Net working cap to sales %23.019.1 120.1%  
Current ratio x1.91.3 141.7%  
Inventory Days Days2526 95.7%  
Debtors Days Days76898 781.1%  
Net fixed assets Rs m9,055103,490 8.7%   
Share capital Rs m184910 20.3%   
"Free" reserves Rs m10,092122,246 8.3%   
Net worth Rs m10,276123,156 8.3%   
Long term debt Rs m1,435275 521.6%   
Total assets Rs m17,137228,003 7.5%  
Interest coverage x8.73.6 240.9%   
Debt to equity ratio x0.10 6,251.7%  
Sales to assets ratio x1.00.7 133.4%   
Return on assets %9.83.2 308.3%  
Return on equity %13.83.6 380.8%  
Return on capital %18.68.0 231.7%  
Exports to sales %47.50-   
Imports to sales %11.50-   
Exports (fob) Rs m7,919NA-   
Imports (cif) Rs m1,917NA-   
Fx inflow Rs m7,91948,057 16.5%   
Fx outflow Rs m1,91721,752 8.8%   
Net fx Rs m6,00226,306 22.8%   
CASH FLOW
From Operations Rs m1,78818,972 9.4%  
From Investments Rs m-2,082-12,868 16.2%  
From Financial Activity Rs m228-3,373 -6.8%  
Net Cashflow Rs m-652,732 -2.4%  

Share Holding

Indian Promoters % 58.7 46.8 125.6%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 21.3 45.8 46.4%  
FIIs % 1.7 16.1 10.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 41.3 53.0 77.9%  
Shareholders   32,600 281,542 11.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Indoco Remedies vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Indoco Remedies vs Lupin Share Price Performance

Period Indoco Remedies Lupin S&P BSE HEALTHCARE
1-Day -1.81% 1.23% 1.18%
1-Month -6.44% 0.15% -0.75%
1-Year 1.11% 151.14% 61.82%
3-Year CAGR 4.71% 17.13% 18.16%
5-Year CAGR 11.97% 17.42% 19.79%

* Compound Annual Growth Rate

Here are more details on the Indoco Remedies share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of Indoco Remedies hold a 58.7% stake in the company. In case of Lupin the stake stands at 47.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Indoco Remedies and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, Indoco Remedies paid a dividend of Rs 2.3 per share. This amounted to a Dividend Payout ratio of 14.6%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at 40.7%.

You may visit here to review the dividend history of Indoco Remedies, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.